Addex Therapeutics (ADXN) Gross Margin (2021 - 2023)
Addex Therapeutics (ADXN) posted Gross Margin of 82.7% for Q2 2023, up 83.78% sequentially from 45.0% in Q2 2022, and up 3770.0% YoY from 2.14% in Q2 2022.
Addex Therapeutics (ADXN) Gross Margin (2021 - 2023) Analysis & Trends
Addex Therapeutics has reported Gross Margin for 3 years, with the latest figure at 82.7% in Q2 2023.
- Quarterly Gross Margin rose 3770.0% year-over-year to 82.7% in Q2 2023, while the trailing twelve-month figure through Jun 2025 was 866.65% (changed N/A YoY) and the FY2024 annual result came in at 95.61%, up 1615.0% from the prior year.
- Gross Margin climbed to 82.7% in Q2 2023 per ADXN's latest filing, from 45.0% in the prior quarter.
- Over five years, Gross Margin peaked at 91.6% in Q2 2021 and troughed at 45.0% in Q2 2022.
- A 3-year average of 73.1% and a median of 82.7% in 2023 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2023: Gross Margin plunged 4661 bps in 2022, then soared 3770 bps in 2023.
- Over 3 years, Gross Margin stood at 91.6% in 2021, then plunged by 51 bps to 45.0% in 2022, then surged by 84 bps to 82.7% in 2023.
- According to Business Quant data, Gross Margin over the past three periods registered 82.7%, 45.0%, and 91.6% for Q2 2023, Q2 2022, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 76.90% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 84.20% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 63.27% |
| 10 | Addex Therapeutics | 515.38 Mn | 515.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 82.70% |
| Jun 30, 2022 | 45.00% |
| Jun 30, 2021 | 91.60% |